Header Logo

Connection

JEFFREY ROSEN to Mice

Back to Details
This is a "connection" page, showing publications JEFFREY ROSEN has written about Mice.
JEFFREY ROSEN
Connection Strength
2.292
Mice
  1. CREB-binding protein/P300 bromodomain inhibition reduces neutrophil accumulation and activates antitumor immunity in triple-negative breast cancer. JCI Insight. 2024 Sep 17; 9(20).
    View in: PubMed
    Score: 0.071
  2. Targeting eIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer. J Clin Invest. 2023 12 15; 133(24).
    View in: PubMed
    Score: 0.067
  3. Targeted Inhibition of lncRNA Malat1 Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer. Cancer Immunol Res. 2023 11 01; 11(11):1462-1479.
    View in: PubMed
    Score: 0.067
  4. Chemotherapy Coupled to Macrophage Inhibition Induces T-cell and B-cell Infiltration and Durable Regression in Triple-Negative Breast Cancer. Cancer Res. 2022 06 15; 82(12):2281-2297.
    View in: PubMed
    Score: 0.060
  5. Tumor suppressor PLK2 may serve as a biomarker in triple-negative breast cancer for improved response to PLK1 therapeutics. Cancer Res Commun. 2021 12; 1(3):178-193.
    View in: PubMed
    Score: 0.059
  6. Morphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition. Nat Commun. 2021 07 12; 12(1):4262.
    View in: PubMed
    Score: 0.057
  7. TIME Is a Great Healer-Targeting Myeloid Cells in the Tumor Immune Microenvironment to Improve Triple-Negative Breast Cancer Outcomes. Cells. 2020 12 23; 10(1).
    View in: PubMed
    Score: 0.055
  8. miR-205 Regulates Basal Cell Identity and Stem Cell Regenerative Potential During Mammary Reconstitution. Stem Cells. 2018 12; 36(12):1875-1889.
    View in: PubMed
    Score: 0.047
  9. FGFR1-Activated Translation of WNT Pathway Components with Structured 5' UTRs Is Vulnerable to Inhibition of EIF4A-Dependent Translation Initiation. Cancer Res. 2018 08 01; 78(15):4229-4240.
    View in: PubMed
    Score: 0.046
  10. Ror2-mediated alternative Wnt signaling regulates cell fate and adhesion during mammary tumor progression. Oncogene. 2017 10 26; 36(43):5958-5968.
    View in: PubMed
    Score: 0.043
  11. Upregulation of EGFR signaling is correlated with tumor stroma remodeling and tumor recurrence in FGFR1-driven breast cancer. Breast Cancer Res. 2015 Nov 18; 17:141.
    View in: PubMed
    Score: 0.038
  12. Mammary Stem Cells and Tumor-Initiating Cells Are More Resistant to Apoptosis and Exhibit Increased DNA Repair Activity in Response to DNA Damage. Stem Cell Reports. 2015 Sep 08; 5(3):378-91.
    View in: PubMed
    Score: 0.038
  13. The mammary stem cell hierarchy: a looking glass into heterogeneous breast cancer landscapes. Endocr Relat Cancer. 2015 Dec; 22(6):T161-76.
    View in: PubMed
    Score: 0.037
  14. Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential. Oncogene. 2015 Dec 03; 34(49):5997-6006.
    View in: PubMed
    Score: 0.037
  15. Intratumoral heterogeneity in a Trp53-null mouse model of human breast cancer. Cancer Discov. 2015 May; 5(5):520-33.
    View in: PubMed
    Score: 0.036
  16. Ror2 regulates branching, differentiation, and actin-cytoskeletal dynamics within the mammary epithelium. J Cell Biol. 2015 Feb 02; 208(3):351-66.
    View in: PubMed
    Score: 0.036
  17. Plk2 regulates mitotic spindle orientation and mammary gland development. Development. 2014 Apr; 141(7):1562-71.
    View in: PubMed
    Score: 0.034
  18. Paracrine signaling in mammary gland development: what can we learn about intratumoral heterogeneity? Breast Cancer Res. 2014 Jan 29; 16(1):202.
    View in: PubMed
    Score: 0.034
  19. Fibroblast growth factor receptor signaling is essential for normal mammary gland development and stem cell function. Stem Cells. 2013 Jan; 31(1):178-89.
    View in: PubMed
    Score: 0.031
  20. Pregnancy-induced noncoding RNA (PINC) associates with polycomb repressive complex 2 and regulates mammary epithelial differentiation. PLoS Genet. 2012; 8(7):e1002840.
    View in: PubMed
    Score: 0.030
  21. On murine mammary epithelial stem cells: discovery, function, and current status. Cold Spring Harb Perspect Biol. 2012 Apr 01; 4(4):a013268.
    View in: PubMed
    Score: 0.030
  22. Stem cell antigen-1 (sca-1) regulates mammary tumor development and cell migration. PLoS One. 2011; 6(11):e27841.
    View in: PubMed
    Score: 0.029
  23. P190A RhoGAP is required for mammary gland development. Dev Biol. 2011 Dec 01; 360(1):1-10.
    View in: PubMed
    Score: 0.029
  24. Identification and gene expression profiling of tumor-initiating cells isolated from human osteosarcoma cell lines in an orthotopic mouse model. Cancer Biol Ther. 2011 Aug 15; 12(4):278-87.
    View in: PubMed
    Score: 0.029
  25. Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells. Proc Natl Acad Sci U S A. 2012 Feb 21; 109(8):2778-83.
    View in: PubMed
    Score: 0.028
  26. Thermal enhancement with optically activated gold nanoshells sensitizes breast cancer stem cells to radiation therapy. Sci Transl Med. 2010 Oct 27; 2(55):55ra79.
    View in: PubMed
    Score: 0.027
  27. Fibroblast growth factor receptor signaling dramatically accelerates tumorigenesis and enhances oncoprotein translation in the mouse mammary tumor virus-Wnt-1 mouse model of breast cancer. Cancer Res. 2010 Jun 15; 70(12):4868-79.
    View in: PubMed
    Score: 0.026
  28. The ups and downs of miR-205: identifying the roles of miR-205 in mammary gland development and breast cancer. RNA Biol. 2010 May-Jun; 7(3):300-4.
    View in: PubMed
    Score: 0.026
  29. CCAAT/enhancer binding protein beta regulates stem cell activity and specifies luminal cell fate in the mammary gland. Stem Cells. 2010 Mar 31; 28(3):535-44.
    View in: PubMed
    Score: 0.026
  30. Selective targeting of radiation-resistant tumor-initiating cells. Proc Natl Acad Sci U S A. 2010 Feb 23; 107(8):3522-7.
    View in: PubMed
    Score: 0.026
  31. A putative role for microRNA-205 in mammary epithelial cell progenitors. J Cell Sci. 2010 Feb 15; 123(Pt 4):606-18.
    View in: PubMed
    Score: 0.026
  32. Chk1 haploinsufficiency results in anemia and defective erythropoiesis. PLoS One. 2010 Jan 05; 5(1):e8581.
    View in: PubMed
    Score: 0.026
  33. Haploinsufficiency for p190B RhoGAP inhibits MMTV-Neu tumor progression. Breast Cancer Res. 2009; 11(4):R61.
    View in: PubMed
    Score: 0.025
  34. The increasing complexity of the cancer stem cell paradigm. Science. 2009 Jun 26; 324(5935):1670-3.
    View in: PubMed
    Score: 0.025
  35. Lactogenic hormonal induction of long distance interactions between beta-casein gene regulatory elements. J Biol Chem. 2009 Aug 21; 284(34):22815-24.
    View in: PubMed
    Score: 0.025
  36. The DNA-damage effector checkpoint kinase 1 is essential for chromosome segregation and cytokinesis. Proc Natl Acad Sci U S A. 2009 Mar 31; 106(13):5159-64.
    View in: PubMed
    Score: 0.024
  37. Identification of tumor-initiating cells in a p53-null mouse model of breast cancer. Cancer Res. 2008 Jun 15; 68(12):4674-82.
    View in: PubMed
    Score: 0.023
  38. Minireview: hormones and mammary cell fate--what will I become when I grow up? Endocrinology. 2008 Sep; 149(9):4317-21.
    View in: PubMed
    Score: 0.023
  39. Modelling breast cancer: one size does not fit all. Nat Rev Cancer. 2007 Sep; 7(9):659-72.
    View in: PubMed
    Score: 0.022
  40. Crosstalk between the p190-B RhoGAP and IGF signaling pathways is required for embryonic mammary bud development. Dev Biol. 2007 Sep 01; 309(1):137-49.
    View in: PubMed
    Score: 0.021
  41. Distinct roles of fibroblast growth factor receptor 1 and 2 in regulating cell survival and epithelial-mesenchymal transition. Mol Endocrinol. 2007 Apr; 21(4):987-1000.
    View in: PubMed
    Score: 0.021
  42. Wnt/beta-catenin mediates radiation resistance of Sca1+ progenitors in an immortalized mammary gland cell line. J Cell Sci. 2007 Feb 01; 120(Pt 3):468-77.
    View in: PubMed
    Score: 0.021
  43. WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc Natl Acad Sci U S A. 2007 Jan 09; 104(2):618-23.
    View in: PubMed
    Score: 0.021
  44. Keratin 6 is not essential for mammary gland development. Breast Cancer Res. 2006; 8(3):R29.
    View in: PubMed
    Score: 0.020
  45. Integration of prolactin and glucocorticoid signaling at the beta-casein promoter and enhancer by ordered recruitment of specific transcription factors and chromatin modifiers. Mol Endocrinol. 2006 Oct; 20(10):2355-68.
    View in: PubMed
    Score: 0.020
  46. A critical role for the inflammatory response in a mouse model of preneoplastic progression. Cancer Res. 2006 Jun 01; 66(11):5676-85.
    View in: PubMed
    Score: 0.020
  47. P190-B Rho GTPase-activating protein overexpression disrupts ductal morphogenesis and induces hyperplastic lesions in the developing mammary gland. Mol Endocrinol. 2006 Jun; 20(6):1391-405.
    View in: PubMed
    Score: 0.019
  48. Stop! In the name of transforming growth factor-beta: keeping estrogen receptor-alpha-positive mammary epithelial cells from proliferating. Breast Cancer Res. 2006; 8(4):106.
    View in: PubMed
    Score: 0.019
  49. Pleiotropic effects of FGFR1 on cell proliferation, survival, and migration in a 3D mammary epithelial cell model. J Cell Biol. 2005 Nov 21; 171(4):663-73.
    View in: PubMed
    Score: 0.019
  50. Transcriptional profiling of mammary gland side population cells. Stem Cells. 2006 Apr; 24(4):1065-74.
    View in: PubMed
    Score: 0.019
  51. Cell cycle defects contribute to a block in hormone-induced mammary gland proliferation in CCAAT/enhancer-binding protein (C/EBPbeta)-null mice. J Biol Chem. 2005 Oct 28; 280(43):36301-9.
    View in: PubMed
    Score: 0.019
  52. Biguanides antithetically regulate tumor properties by the dose-dependent mitochondrial reprogramming-driven c-Src pathway. Cell Rep Med. 2025 Feb 18; 6(2):101941.
    View in: PubMed
    Score: 0.018
  53. Stem/progenitor cells in mouse mammary gland development and breast cancer. J Mammary Gland Biol Neoplasia. 2005 Jan; 10(1):17-24.
    View in: PubMed
    Score: 0.018
  54. Chk1 versus Cdc25: chking one's levels of cellular proliferation. Cell Cycle. 2004 Nov; 3(11):1355-7.
    View in: PubMed
    Score: 0.018
  55. IRE1a silences dsRNA to prevent taxane-induced pyroptosis in triple-negative breast cancer. Cell. 2024 Dec 12; 187(25):7248-7266.e34.
    View in: PubMed
    Score: 0.018
  56. Chk1 is haploinsufficient for multiple functions critical to tumor suppression. Cancer Cell. 2004 Jul; 6(1):45-59.
    View in: PubMed
    Score: 0.017
  57. Multispecies comparative analysis of a mammalian-specific genomic domain encoding secretory proteins. Genomics. 2003 Oct; 82(4):417-32.
    View in: PubMed
    Score: 0.017
  58. Pregnancy-induced changes in cell-fate in the mammary gland. Breast Cancer Res. 2003; 5(4):192-7.
    View in: PubMed
    Score: 0.016
  59. The role of C/EBPbeta in mammary gland development and breast cancer. J Mammary Gland Biol Neoplasia. 2003 Apr; 8(2):191-204.
    View in: PubMed
    Score: 0.016
  60. A beta-catenin survival signal is required for normal lobular development in the mammary gland. J Cell Sci. 2003 Mar 15; 116(Pt 6):1137-49.
    View in: PubMed
    Score: 0.016
  61. p190-B RhoGAP regulates mammary ductal morphogenesis. Mol Endocrinol. 2003 Jun; 17(6):1054-65.
    View in: PubMed
    Score: 0.016
  62. LEF1 Drives a Central Memory Program and Supports Antitumor Activity of Natural Killer T Cells. Cancer Immunol Res. 2023 02 03; 11(2):171-183.
    View in: PubMed
    Score: 0.016
  63. Disruption of steroid and prolactin receptor patterning in the mammary gland correlates with a block in lobuloalveolar development. Mol Endocrinol. 2002 Dec; 16(12):2675-91.
    View in: PubMed
    Score: 0.016
  64. STAT5 confers lactogenic properties in breast tumorigenesis and restricts metastatic potential. Oncogene. 2022 11; 41(48):5214-5222.
    View in: PubMed
    Score: 0.015
  65. Inducible dimerization of FGFR1: development of a mouse model to analyze progressive transformation of the mammary gland. J Cell Biol. 2002 May 13; 157(4):703-14.
    View in: PubMed
    Score: 0.015
  66. CD8+ T cells inhibit metastasis and CXCL4 regulates its function. Br J Cancer. 2021 07; 125(2):176-189.
    View in: PubMed
    Score: 0.014
  67. Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer. Cell. 2021 01 21; 184(2):384-403.e21.
    View in: PubMed
    Score: 0.014
  68. Protein quality control through endoplasmic reticulum-associated degradation maintains haematopoietic stem cell identity and niche interactions. Nat Cell Biol. 2020 10; 22(10):1162-1169.
    View in: PubMed
    Score: 0.013
  69. Resistance to natural killer cell immunosurveillance confers a selective advantage to polyclonal metastasis. Nat Cancer. 2020 07; 1(7):709-722.
    View in: PubMed
    Score: 0.013
  70. Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer. J Vis Exp. 2020 05 18; (159).
    View in: PubMed
    Score: 0.013
  71. The MMTV-Wnt1 murine model produces two phenotypically distinct subtypes of mammary tumors with unique therapeutic responses to an EGFR inhibitor. Dis Model Mech. 2019 07 05; 12(7).
    View in: PubMed
    Score: 0.012
  72. A transgenic mouse model for mammary carcinogenesis. Oncogene. 1998 Feb 26; 16(8):997-1007.
    View in: PubMed
    Score: 0.011
  73. Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer. J Clin Invest. 2018 04 02; 128(4):1283-1299.
    View in: PubMed
    Score: 0.011
  74. Use of PRKO mice to study the role of progesterone in mammary gland development. J Mammary Gland Biol Neoplasia. 1997 Oct; 2(4):343-54.
    View in: PubMed
    Score: 0.011
  75. TAp63 suppresses mammary tumorigenesis through regulation of the Hippo pathway. Oncogene. 2017 04 27; 36(17):2377-2393.
    View in: PubMed
    Score: 0.010
  76. Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation. Nat Cell Biol. 2016 06; 18(6):632-44.
    View in: PubMed
    Score: 0.010
  77. A Geometrically-Constrained Mathematical Model of Mammary Gland Ductal Elongation Reveals Novel Cellular Dynamics within the Terminal End Bud. PLoS Comput Biol. 2016 Apr; 12(4):e1004839.
    View in: PubMed
    Score: 0.010
  78. The mammary gland as a bioreactor: factors regulating the efficient expression of milk protein-based transgenes. Am J Clin Nutr. 1996 Apr; 63(4):627S-32S.
    View in: PubMed
    Score: 0.010
  79. Engineering transgenes for use in the mammary gland. Genet Eng (N Y). 1996; 18:57-81.
    View in: PubMed
    Score: 0.010
  80. Cross-species DNA copy number analyses identifies multiple 1q21-q23 subtype-specific driver genes for breast cancer. Breast Cancer Res Treat. 2015 Jul; 152(2):347-56.
    View in: PubMed
    Score: 0.009
  81. The oncogenic STP axis promotes triple-negative breast cancer via degradation of the REST tumor suppressor. Cell Rep. 2014 Nov 20; 9(4):1318-32.
    View in: PubMed
    Score: 0.009
  82. Wnt-responsive cancer stem cells are located close to distorted blood vessels and not in hypoxic regions in a p53-null mouse model of human breast cancer. Stem Cells Transl Med. 2014 Jul; 3(7):857-66.
    View in: PubMed
    Score: 0.009
  83. The regulation of mammary gland development by hormones, growth factors, and oncogenes. Prog Clin Biol Res. 1994; 387:95-111.
    View in: PubMed
    Score: 0.008
  84. Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts. Genome Biol. 2013 Nov 12; 14(11):R125.
    View in: PubMed
    Score: 0.008
  85. Predicting drug responsiveness in human cancers using genetically engineered mice. Clin Cancer Res. 2013 Sep 01; 19(17):4889-99.
    View in: PubMed
    Score: 0.008
  86. Separation by cell size enriches for mammary stem cell repopulation activity. Stem Cells Transl Med. 2013 Mar; 2(3):199-203.
    View in: PubMed
    Score: 0.008
  87. FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer. Cancer Res. 2013 Mar 15; 73(6):1981-92.
    View in: PubMed
    Score: 0.008
  88. Epigenetic silencing of microRNA-203 is required for EMT and cancer stem cell properties. Sci Rep. 2013; 3:2687.
    View in: PubMed
    Score: 0.008
  89. Targeting CreER(T2) expression to keratin 8-expressing murine simple epithelia using bacterial artificial chromosome transgenesis. Transgenic Res. 2012 Oct; 21(5):1117-23.
    View in: PubMed
    Score: 0.007
  90. Activation of Wnt signaling by chemically induced dimerization of LRP5 disrupts cellular homeostasis. PLoS One. 2012; 7(1):e30814.
    View in: PubMed
    Score: 0.007
  91. Casein gene expression: from transfection to transgenics. Cancer Treat Res. 1992; 61:379-97.
    View in: PubMed
    Score: 0.007
  92. Progesterone receptor directly inhibits ?-casein gene transcription in mammary epithelial cells through promoting promoter and enhancer repressive chromatin modifications. Mol Endocrinol. 2011 Jun; 25(6):955-68.
    View in: PubMed
    Score: 0.007
  93. Prospective isolation and characterization of committed and multipotent progenitors from immortalized mouse mammary epithelial cells with morphogenic potential. Breast Cancer Res. 2011 Apr 05; 13(2):R41.
    View in: PubMed
    Score: 0.007
  94. The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo. Proc Natl Acad Sci U S A. 2011 Mar 01; 108(9):3665-70.
    View in: PubMed
    Score: 0.007
  95. Altered differentiation and paracrine stimulation of mammary epithelial cell proliferation by conditionally activated Smoothened. Dev Biol. 2011 Apr 01; 352(1):116-27.
    View in: PubMed
    Score: 0.007
  96. Early-onset aging and defective DNA damage response in Cdc14b-deficient mice. Mol Cell Biol. 2011 Apr; 31(7):1470-7.
    View in: PubMed
    Score: 0.007
  97. P190B RhoGAP has pro-tumorigenic functions during MMTV-Neu mammary tumorigenesis and metastasis. Breast Cancer Res. 2010; 12(5):R73.
    View in: PubMed
    Score: 0.007
  98. Genetic manipulation of individual somatic mammary cells in vivo reveals a master role of STAT5a in inducing alveolar fate commitment and lactogenesis even in the absence of ovarian hormones. Dev Biol. 2010 Oct 15; 346(2):196-203.
    View in: PubMed
    Score: 0.007
  99. Defining the ATM-mediated barrier to tumorigenesis in somatic mammary cells following ErbB2 activation. Proc Natl Acad Sci U S A. 2010 Feb 23; 107(8):3728-33.
    View in: PubMed
    Score: 0.006
  100. Fibroblast growth factor receptor 1-transformed mammary epithelial cells are dependent on RSK activity for growth and survival. Cancer Res. 2009 Mar 15; 69(6):2244-51.
    View in: PubMed
    Score: 0.006
  101. An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situ. Breast Cancer Res. 2009; 11(5):R66.
    View in: PubMed
    Score: 0.006
  102. Mammary gland macrophages: pleiotropic functions in mammary development. J Mammary Gland Biol Neoplasia. 2006 Oct; 11(3-4):229-38.
    View in: PubMed
    Score: 0.005
  103. Progesterone receptor repression of prolactin/signal transducer and activator of transcription 5-mediated transcription of the beta-casein gene in mammary epithelial cells. Mol Endocrinol. 2007 Jan; 21(1):106-25.
    View in: PubMed
    Score: 0.005
  104. Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc Natl Acad Sci U S A. 2003 Dec 23; 100(26):15853-8.
    View in: PubMed
    Score: 0.004
  105. Inducible prostate intraepithelial neoplasia with reversible hyperplasia in conditional FGFR1-expressing mice. Cancer Res. 2003 Dec 01; 63(23):8256-63.
    View in: PubMed
    Score: 0.004
  106. Prostate-specific expression of p53(R172L) differentially regulates p21, Bax, and mdm2 to inhibit prostate cancer progression and prolong survival. Mol Cancer Res. 2003 Dec; 1(14):1036-47.
    View in: PubMed
    Score: 0.004
  107. Conditional activation of fibroblast growth factor receptor (FGFR) 1, but not FGFR2, in prostate cancer cells leads to increased osteopontin induction, extracellular signal-regulated kinase activation, and in vivo proliferation. Cancer Res. 2003 Oct 01; 63(19):6237-43.
    View in: PubMed
    Score: 0.004
  108. Hormone dependence in premalignant mammary progression. Cancer Res. 2003 Mar 01; 63(5):1067-72.
    View in: PubMed
    Score: 0.004
  109. The mineralocorticoid receptor may compensate for the loss of the glucocorticoid receptor at specific stages of mammary gland development. Mol Endocrinol. 2002 Sep; 16(9):2008-18.
    View in: PubMed
    Score: 0.004
  110. Comparative sequence analysis of the mRNAs coding for mouse and rat whey protein. Nucleic Acids Res. 1982 Jun 25; 10(12):3733-44.
    View in: PubMed
    Score: 0.004
  111. Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population. Dev Biol. 2002 May 01; 245(1):42-56.
    View in: PubMed
    Score: 0.004
  112. Jak2 is an essential tyrosine kinase involved in pregnancy-mediated development of mammary secretory epithelium. Mol Endocrinol. 2002 Mar; 16(3):563-70.
    View in: PubMed
    Score: 0.004
  113. Mechanisms of hormonal prevention of breast cancer. Ann N Y Acad Sci. 2001 Dec; 952:23-35.
    View in: PubMed
    Score: 0.004
  114. Signal transducer and activator of transcription (Stat) 5 controls the proliferation and differentiation of mammary alveolar epithelium. J Cell Biol. 2001 Nov 12; 155(4):531-42.
    View in: PubMed
    Score: 0.004
  115. Long term effects of perinatal injection of estrogen and progesterone on the morphological and biochemical development of the mammary gland. Endocrinology. 1980 Mar; 106(3):823-32.
    View in: PubMed
    Score: 0.003
  116. Detection of casein messenger RNA in hormone-dependent mammary cancer by molecular hybridisation. Nature. 1977 Sep 01; 269(5623):83-6.
    View in: PubMed
    Score: 0.003
  117. neu/ERBB2 cooperates with p53-172H during mammary tumorigenesis in transgenic mice. Mol Cell Biol. 1997 Jun; 17(6):3155-63.
    View in: PubMed
    Score: 0.003
  118. Quantitation of casein messenger ribonucleic acid sequences using a specific complementary DNA hybridization probe. Biochemistry. 1976 Nov 30; 15(24):5272-80.
    View in: PubMed
    Score: 0.003
  119. Isolation and characterization of purified rat casein messenger ribonucleic acids. Biochemistry. 1976 Nov 30; 15(24):5263-71.
    View in: PubMed
    Score: 0.003
  120. Comparative biochemical studies of adriamycin and daunomycin in leukemic cells. Cancer Res. 1972 Mar; 32(3):511-5.
    View in: PubMed
    Score: 0.002
  121. Inhibitory effect of cortisol in vitro on 2-deoxyglucose uptake and RNA and protein metabolism in lymphosarcoma P1798. Cancer Res. 1972 Feb; 32(2):350-5.
    View in: PubMed
    Score: 0.002
  122. A comparison of the effect of glucocorticoids on glucose uptake and hexokinase activity in lymphosarcoma P1798. Biochim Biophys Acta. 1970 Dec 01; 219(2):447-54.
    View in: PubMed
    Score: 0.002
  123. Inhibition of glucose uptake in lymphosarcoma P1798 by cortisol and its relationship to the biosynthesis of deoxyribonucleic acid. J Biol Chem. 1970 Apr 25; 245(8):2074-80.
    View in: PubMed
    Score: 0.002
  124. Effects of cortisol on DNA metabolism in the sensitive and resistant lines of mouse lymphoma P1798. Cancer Res. 1970 Apr; 30(4):1129-36.
    View in: PubMed
    Score: 0.002
  125. Comparison of the whey acidic protein genes of the rat and mouse. Nucleic Acids Res. 1984 Nov 26; 12(22):8685-97.
    View in: PubMed
    Score: 0.001
  126. Localization of the casein gene family to a single mouse chromosome. J Cell Biol. 1982 Apr; 93(1):199-204.
    View in: PubMed
    Score: 0.001
  127. Difference between mammary epithelial cells from mature virgin and primiparous mice. Cancer Res. 1978 Nov; 38(11 Pt 2):4059-65.
    View in: PubMed
    Score: 0.001
  128. Mammary tumour virus and casein gene transcription during mouse mammary development. Nature. 1978 Oct 05; 275(5679):455-7.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.